Financials ViroGates A/S

Equities

VIRO

DK0061030574

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen 10:42:21 2023-12-01 am EST Intraday chart for ViroGates A/S 5-day change 1st Jan Change
6.780 DKK +6.27% -22.07% -83.09%

Valuation

Fiscal Period : December 2018 2019 2020 2021 2022
Capitalization 1 182 104 255 456 134
Enterprise Value (EV) 1 122 62,6 221 441 124
P/E ratio -9,31x -5,54x -13,4x -25,7x -13,5x
Yield - - - - -
Capitalization / Revenue 54,9x 29,0x 47,5x 59,6x 8,83x
EV / Revenue 36,7x 17,5x 41,3x 57,6x 8,18x
EV / EBITDA -6,78x -3,19x -11,3x -23,8x -11,7x
EV / FCF -10,9x -5,07x -23,3x -28,2x -10,8x
FCF Yield -9,21% -19,7% -4,29% -3,54% -9,23%
Price to Book 2,98x 2,46x 8,13x 27,8x 8,34x
Nbr of stocks (in thousands) 3 032 3 032 3 123 3 167 3 348
Reference price 2 60,0 34,3 81,5 144 40,1
Announcement Date 27/03/19 29/02/20 01/03/21 23/03/22 23/03/23
1DKK in Million2DKK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period : December 2017 2018 2019 2020 2021 2022
Net sales 1 2,44 3,32 3,58 5,35 7,66 15,2
EBITDA 1 -7,57 -18,0 -19,6 -19,5 -18,6 -10,7
EBIT 1 -7,69 -18,1 -19,7 -19,7 -18,8 -10,8
Operating Margin -315% -546% -551% -368% -245% -71,4%
Earnings before Tax (EBT) 1 -7,70 -18,9 -20,0 -20,0 -19,0 -10,9
Net income 1 -5,99 -17,0 -18,8 -18,7 -17,7 -9,65
Net margin -245% -512% -525% -350% -231% -63,5%
EPS 2 -2,71 -6,44 -6,20 -6,08 -5,60 -2,96
Free Cash Flow 1 -5,19 -11,2 -12,3 -9,49 -15,6 -11,5
FCF margin -213% -338% -344% -177% -204% -75,5%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 04/23/18 03/27/19 02/29/20 03/01/21 03/23/22 03/23/23
1DKK in Million2DKK
Estimates

Balance Sheet Analysis

Fiscal Period : December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 1,47 60,1 41,4 33,5 14,9 9,88
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -5,19 -11,2 -12,3 -9,49 -15,6 -11,5
ROE (net income / shareholders' equity) -99,9% -53,1% -36,4% -51,0% -74,0% -59,3%
Shareholders' equity 1 5,99 32,0 51,6 36,8 23,9 16,3
ROA (Net income/ Total Assets) -56,6% -33,1% -22,7% -29,6% -40,2% -35,9%
Assets 1 10,6 51,3 82,8 63,4 44,0 26,9
Book Value Per Share 2 1,36 20,1 13,9 10,0 5,19 4,81
Cash Flow per Share 2 0,66 19,8 13,7 10,7 4,69 2,95
Capex 1 0,13 - 0,55 0,11 - -
Capex / Sales 5,33% - 15,2% 2,13% - -
Announcement Date 23/04/18 27/03/19 29/02/20 01/03/21 23/03/22 23/03/23
1DKK in Million2DKK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration
fermer